Skip Navigation
Search Menu
Find an Expert

 


John Joseph Laterra, M.D., Ph.D.

Photo of Dr. John Joseph Laterra, M.D., Ph.D.

Co-Director, Brain Cancer Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Professor of Neurology

Male

Expertise: Brain Tumors, Neurology

Research Interests: Mechanisms of Brain Cancer Stem Cell Regulation

Request an Appointment

I live in Maryland

410-614-3853
Request an appointment through MyChart!

I live outside of Maryland

410-464-6641
Request Appointment

I live outside of the United States

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital
Appointment Phone: 410-614-3853

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map

Johns Hopkins Outpatient Center
Appointment Phone: 410-614-3853

601 N. Caroline St.
Baltimore, MD 21287 map

Background

As Professor of Neurology, Oncology and Neuroscience and co-Director of the Brain Cancer Program at the Johns Hopkins Kimmel Cancer Center, Dr. John Laterra focuses on the diagnosis and treatment of patients with primary brain tumors and neurological complications of systemic cancer.

Dr. Laterra is internationally recognized for his clinical expertise and research on mechanisms of brain tumor malignancy, tumor vascular biology and the identification of new therapeutic targets in gliomas. Dr. Laterra's research is funded by the National Institutes of Health and numerous private foundations.

...read more

Titles

  • Co-Director, Brain Cancer Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
  • Director, Division of Neuro-Oncology
  • Professor of Neurology
  • Professor of Neuroscience
  • Professor of Oncology

Departments / Divisions

Education

Degrees

  • MD, St. Vincent Charity Medical Center (1984)

Residencies

  • University of Michigan Health System / Neurology (1988)

Board Certifications

  • American Board of Psychiatry & Neurology / Neurology-General (1990)

Research & Publications

Selected Publications

View all on Pubmed

Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P and Laterra J: Reversion of human glioblastoma malignancy by U1snRNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met gene expression. J Natl Cancer Inst, 91:1548-1556, 1999. PMID: 10491431.

Kim KJ, Wang L, Su, YC, Gillespie GY, Salhotra A, Lal B and Laterra J. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin Cancer Res, 12(4):1292-1298, 2006. PMID: 16489086

Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Yan K, Wang S, Fu D-X, Blakeley J, Ford E, Tyler B, Laterra J, and van Zijl PCM: Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nature Med.2011 Jan; 17(1): 130-4. Epub Dec 19 2010. PMID: 21170048, PMCID: PMC3058561.

Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Scheffler B, Laterra J: c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci U S A. 108:9951-6, 2011. PMID: 21628563; PMCID: PMC3116406.

Lopez-Bertoni H, Lal B, Michelson H, Guerrero-Cázares H, Quiñones-Hinojosa A, Li Y, Laterra J. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells. Oncogene, 2016 Feb 22. doi: 10.1038/onc.2016.22. [Epub ahead of print].

Activities & Honors

Memberships

  • Jounral of Neuro-Oncology
    Associate Editor
  • Scientific Advisory Board of the American Brain Tumor Associaton
  • The Society of Neuro-Oncology
    Charter Member
Is this you? Edit Profile